您当前的位置：
首页 >
文章列表页 >
Guidelines for the management of therapeutic drug monitoring
更新时间：2026-06-10

    • Guidelines for the management of therapeutic drug monitoring

    • ZHONGGUO YAOFANG   Vol. 37, Issue 11, Pages: 1381-1392(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.11.01    

      CLC： R98

    • Received：27 January 2026，

      Revised：2026-05-26，

      Accepted：28 May 2026，

      Published：15 June 2026

    移动端阅览

  • LI Zhengxiang,MIAO Liyan,DUAN Rong,et al.Guidelines for the management of therapeutic drug monitoring[J].ZHONGGUO YAOFANG,2026,37(11):1381-1392. DOI： 10.6039/j.issn.1001-0408.2026.11.01.

  •  
  •  

0

Views

70

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Construction of the research question system of the Guideline for the Management of Therapeutic Drug Monitoring based on modified Delphi method
Establishment and application of a determination method for plasma concentrations of venetoclax， busulfan and voriconazole in patients with acute myeloid leukemia
Establishment and clinical application of a method for the determination of tacrolimus concentration in human whole blood
Analysis of the characteristics and influencing factors of mirtazapine steady-state trough concentration and concentration-to-dose ratio
Evaluation of the effect of clinical pharmacists participating in the treatment of chronic heart failure based on the clinical pharmacy pathway

Related Author

DUAN Rong
MIAO Liyan
LI Zhengxiang
ZHANG Zhenhua
ZHANG Mengru
GUO Aoxiang
CHEN Hui
XIANG Shijian

Related Institution

Dept. of Pharmacy， the First Affiliated Hospital of Soochow University
Tianjin Center for Drug Use Monitoring and Clinical Comprehensive Evaluation
Pharmacy Center， Tianjin Medical University General Hospital
Shenzhen Key Laboratory of Chinese Medicine Active Substance Screening and Translational Research
School of Pharmaceutical Sciences （Shenzhen）， Sun Yat-sen University
0